Skip to main content

Advertisement

Table 3 Baseline characteristics of the study population

From: Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14)

  Metabolic Syndrome
Variables Overall Men Women
  Absent Present p Absent Present p Absent Present p
  n = 371 n = 1043   n = 260 n = 490   n = 111 n = 553  
Age (years) 57.0 ± 10.3 56.1 ± 9.9 0.119 57.1 ± 10.5 56.8 ± 10.5 0.664 56.8 ± 9.8 55.4 ± 9.4 0.181
HbA1C (%) 8.3 ± 2.4 8.2 ± 2.1 0.366 8.3 ± 2.4 8.2 ± 2.1 0.475 8.2 ± 2.6 8.1 ± 2.1 0.687
Duration of diabetes (years) 6.6 ± 7.5 5.1 ± 5.7 < 0.0001 7.1 ± 8.0 5.7 ± 6.0 0.008 5.5 ± 5.6 4.6 ± 5.3 0.084
Total serum cholesterol (mg/dl) 184.5 ± 40.9 187.2 ± 40.7 0.266 178.1 ± 38.4 183.2 ± 38.4 0.081 199.5 ± 42.8 190.8 ± 42.3 0.048
Serum LDL cholesterol (mg/dl) 113.2 ± 35.9 111.8 ± 35.2 0.506 106.8 ± 33.6 106.3 ± 33.8 0.845 128.2 ± 37.2 116.7 ± 35.8 0.002
Serum Non HDL cholesterol (mg/dl) 3.7 ± 1.0 3.8 ± 1.0 0.029 3.6 ± 0.9 3.8 ± 0.9 0.009 3.9 ± 1.0 3.9 ± 1.1 0.488
Hemoglobin (gm/dl) 13.8 ± 1.8 13.8 ± 1.4 0.884 14.2 ± 1.9 14.5 ± 1.4 0.013 12.7 ± 1.3 13.1 ± 1.1 0.003
  1. HbA1C (%), Glycosylated hemoglobin; LDL, Low density lipoprotein; HDL, High-density lipoprotein